COOPERx Stratégies is a consulting firm specializing in the clinical and pharmacoeconomic evaluation of drugs and health technology.

We have recognized expertise in reimbursement and market access strategies, in particular in the negotiation of product listing and risk-sharing agreements.

We provide highly personalized and results-oriented services. Our clients are true business partners with whom we establish long-term relationships built on mutual trust.

We are proud to offer USOP Rx, the first continuing education platform for healthcare and drug industry professionals regarding optimal drug use and pharmacoeconomics. Visit us at www.usoprx.com

News

February 2020
Watch our special offer to become individual or corporate member of our continuing education web portal on the optimal use of drugs, USOP Rx…
December 2019
In 2019, we have attended several expert committees of provincial, national and international scope in multiple therapeutic areas including oncology, and on new innovative drugs and challenges related to scientific assessment, economy and market access.
December 2019
Participation in the Quebec City Healthcare Industry Forum organized by Québec International.
October 2019
Participation to the annual meeting « Rendez-vous annuel de l’Ordre des pharmaciens du Québec (OPQ) » in Quebec.
VIEW ALL NEWS